©The Author(s) 2025.
World J Biol Chem. Dec 5, 2025; 16(4): 111831
Published online Dec 5, 2025. doi: 10.4331/wjbc.v16.i4.111831
Published online Dec 5, 2025. doi: 10.4331/wjbc.v16.i4.111831
Table 3 Comparative pharmacokinetics and safety profile of citicoline vs α-glycerophosphocholine
| Metric | Citicoline | α-GPC | Key takeaway |
| Elemental choline | 18%-19% | 40%-41% | α-GPC more choline-dense |
| Oral bioavailability | Approximately 95% | Approximately 85% | Both excellent |
| Peak plasma free choline (500 mg eq) | ↑2.6-fold vs baseline[10] | ↑1.8 fold vs baseline[86] | Citicoline faster spike |
| Effect on hepatic PC/PE | ↑PC + PE balance[85] | ↑PC preferentially[86] | Citicoline broader scope |
| TMAO production | Minimal[80] | Moderate↑[87] | Clinically relevant |
| Long-term vascular signal | Neutral (no association) | +46% 10 years stroke risk[9] | Use cautiously |
- Citation: Mercola J. Fatty liver reexamined choline and mitochondrial toxin amelioration. World J Biol Chem 2025; 16(4): 111831
- URL: https://www.wjgnet.com/1949-8454/full/v16/i4/111831.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v16.i4.111831